







People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of developing heart failure years later
Stem cell therapy lowers risk of heart failure after a heart attack
www.newscientist.comNov 1, 2025 at 7:57 AM
Stem cell therapy lowers risk of heart failure after a heart attack | New Scientist
People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of developing heart failure years later

Underlying Conditions and the Higher Risk for Severe COVID-19
Learn risk factors for severe outcomes from COVID-19 and actions to take.
Methylphenidate and Short-Term Cardiovascular Risk
This cohort study examines the risks of cardiovascular disease after 6 months of methylphenidate treatment in individuals with attention-deficit/hyperactivity disorder.

Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health records
Children and young people have higher risks of rare vascular and inflammatory diseases up to 12 months after a first COVID-19 diagnosis and higher risk of rare myocarditis or pericarditis up to 4 weeks after a first BNT162b2 vaccine, although the risk following vaccination is substantially lower than the risk following infection. These findings are of great importance for national policy makers and caregivers considering vaccination consent for children, and support the public health strategy of COVID-19 vaccination in children and young people to mitigate the more frequent and persistent risks associated with SARS-CoV-2 infection.

Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health records
Children and young people have higher risks of rare vascular and inflammatory diseases up to 12 months after a first COVID-19 diagnosis and higher risk of rare myocarditis or pericarditis up to 4 weeks after a first BNT162b2 vaccine, although the risk following vaccination is substantially lower than the risk following infection. These findings are of great importance for national policy makers and caregivers considering vaccination consent for children, and support the public health strategy of COVID-19 vaccination in children and young people to mitigate the more frequent and persistent risks associated with SARS-CoV-2 infection.

It’s Stanford time, baby: 8-hour time-restricted press releases linked to a 91% higher risk of hype
You and the blog readers might find this interesting: https://newsroom.heart.org/news/8-hour-time-restricted-eating-linked-to-a-91-higher-risk-of-cardiovascular-death.
Accelerating life sciences research
Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.

Menopausal hormone therapy and coronary heart disease: the roller-coaster history
In the USA it is estimated that more than one million women become menopausal each year. Coronary heart disease (CHD) is the leading cause of mortality in menopausal woman globally. The majority of...

We live in a golden age of biology. So why are people still dying from disease? Because discovery and development move slower than they should. Today, we’re partnering with Incyte to change… | Samuel G. Rodriques | 491 comments
We live in a golden age of biology. So why are people still dying from disease? Because discovery and development move slower than they should. Today, we’re partnering with Incyte to change that. Kosmos is now the first agent that can compress months of drug development into weeks, from the earliest stages of scientific discovery through to FDA approval. Incyte will be the first company to deploy it across their pipeline. Work that used to take a team of scientists months now happens in weeks. Patients can't wait, and neither can we. | 491 comments on LinkedIn
AI can detect heart disease in women using mammograms, study suggests
Experts say findings mean breast screenings for cancer could also flag cardiovascular problems in women

Opinion | When It Comes to Covid-19, Most of Us Have Risk Exactly Backward (Published 2020)
We aren’t very good at discussing trade-offs, but we need to make some during this pandemic.

‘Unbelievably dangerous’: experts sound alarm after ChatGPT Health fails to recognise medical emergencies
Study finds ChatGPT Health did not recommend a hospital visit when medically necessary in more than half of cases

Does the new shingles vaccine (Shingrix) protect against cardiovascular disease (CVD)? Yes, according to a new 'natural experiment' study in @natmed.nature.com. But the truth is sadly far less convincing! Pull up a chair and let's examine another peer review failure in a Nature journal. 1/10 🧵
A challenge if anyone wants to take it up. Here is a recent review in the BMJ on the "Evidence for clinical interventions targeting the gut microbiome in cardiometabolic disease". There is not a single effect estimate reported in this review, or either supplemental file bmj.com/content/383/bmj-2023-075180
Evidence for clinical interventions targeting the gut microbiome in cardiometabolic disease
www.bmj.comIt worked. Stem cells (mesenchymal) given to patients with a large heart attack reduced major adverse events in a randomized trial vs standard care bmj.com/content/391/bmj-2024-083382
After decades of mixed results, new evidence suggests stem cells really can help the heart heal. The largest trial yet finds stem cell therapy cuts the risk of heart failure by nearly 60% in the years following a heart attack. newscientist.com/article/2502081-stem-cell-the…
Stem cell therapy lowers risk of heart failure after a heart attack
www.newscientist.com